Concepedia

Kerry Townsend

KT

Statistics

Publications

10

Citations

623

H-Index

10

Active since

2014

Affiliations

National Institute of Allergy and Infectious Diseases(Current)

University of Maryland, Baltimore

National Institutes of Health

Gilead Sciences (United States)

Frederick National Laboratory for Cancer Research

Kerry Townsend is an author at National Institute of Allergy and Infectious Diseases specializing in antiviral therapy, pharmacy, and pharmacotherapy.

Publications per year

2014–2017

10

Publications

10

Virologic Response Following Combined Ledipasvir and Sofosbuvir Administration in Patients With HCV Genotype 1 and HIV Co-infection

Anu Osinusi, Kerry Townsend, Anita Kohli et al. · JAMA · 2015 · 203 citations · Full text

, , +17

Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study

Anita Kohli, A. Osinusi, Zayani Sims et al. · The Lancet · 2015 · 151 citations

, , +16

Re-treatment of Chronic Hepatitis C Virus Genotype 1 Infection After Relapse

Anu Osinusi, Anita Kohli, Miriam Marti et al. · Annals of Internal Medicine · 2014 · 73 citations · Full text

, , +17

High adherence to all-oral directly acting antiviral HCV therapy among an inner-city patient population in a phase 2a study

Tess Petersen, Kerry Townsend, Lori A. Gordon et al. · Hepatology International · 2015 · 66 citations · Full text

, , +14

Interferon-Free Treatment of Hepatitis C Virus in HIV/Hepatitis C Virus-Coinfected Subjects Results in Increased Serum Low-Density Lipoprotein Concentration

Kerry Townsend, Eric G. Meissner, Sreetha Sidharthan et al. · AIDS Research and Human Retroviruses · 2015 · 38 citations · Full text

, , +14

1–5 of 10